Open AccessAliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients
Author(s) -
Laima Siddiqi,
P. Liam Oey,
Peter J. Blankestijn
Publication year - 2011
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfq857
Subject(s) - aliskiren , medicine , blood pressure , kidney disease , renal function , plasma renin activity , urology , confidence interval , cardiology , endocrinology , renin–angiotensin system
Hypertensive chronic kidney disease (CKD) patients often have sympathetic hyperactivity. In this pilot study, we evaluated the effect of 6 weeks treatment with aliskiren on sympathetic activity in hypertensive Stages 2-4 CKD patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom